Глобальна гаряча лінія для українських пацієнтів-біженців, які беруть участь у клінічному випробуванні Amgen. Натисніть тут для отримання додаткової інформації.
Глобальная горячая линия для украинских пациентов-беженцев, участвующих в клиническом исследовании Amgen. Для получения дополнительной информации нажмите здесь.
Patients 05.23.2022
Science & Innovation 05.20.2022
In a recent Twitter Spaces conversation, Jean-Charles Soria and Angela Coxon examine how Amgen is accelerating innovative science for cancer patients.
Patients 05.19.2022
Patients 05.12.2022
People & Culture 05.06.2022
A culture of support is just one of the benefits these mothers like about working for Amgen.
COVID-19
Check here for Amgen updates, Amgen product information, public health resources, and other pertinent information related to COVID-19.
PRESS RELEASE
Amgen is a pioneer in the science of using living cells to make biologic medicines.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.
Amgen is a pioneer in the science of using living cells to making biologic medicines, leading and guiding the biotech industry.
Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.
